Home > Analytics > REMEDIUM LIFECARE

REMEDIUM LIFECARE
Intrinsic Value | Fundamental Analysis

BOM : 539561     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : NA
Dec 11,2024
Price(EOD): ₹ 5.47
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Trading
MCap: ₹ 220.55 Cr
Value of ₹ 1 Lac invested in REMEDIUM LIFECARE
on Dec 23,2019 (price: ₹ 0.20)

₹ 1 L

₹ 27.11 L

1W : -0.6% 1M : -18.6% 1Y : -80.2%
COMMUNITY POLL
for REMEDIUM LIFECARE
Please provide your vote to see the results
REMEDIUM LIFECARE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
REMEDIUM LIFECARE -0.6% -18.6% -80.2%
ADANI ENTERPRISES -2.7% -16.2% -14.6%
REDINGTON 3.5% 11.9% 22.5%
HONASA CONSUMER -5% -31.9% -34.6%
MMTC 1.2% 3.4% 47.7%
MSTC 1.4% 21.7% 74%
LLOYDS ENTERPRISES -0.7% 1.3% 7.7%
VERITAS (INDIA) -2.1% -3.8% 133.3%
NOVARTIS INDIA -4.1% -6.2% 45.1%

FUNDAMENTAL ANALYSIS OF REMEDIUM LIFECARE

 
Fundamentals Score
[ Q(TTM): Sep2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF REMEDIUM LIFECARE

 
Valuation Score
[As on : Dec 11,2024 ]

Ratio Standalone
P/E
P/B
P/S
11.94
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 18.47 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

5.13
P/B Calculated based on Book Value of Rs 42.96 Cr
[Latest Year - Mar2024 - Standalone Results ]

0.07
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ]

Financial Ratios →

Insights 💡 REMEDIUM LIFECARE is one of the potential top 8% undervalued companies ! Discover More →

FAIR VALUE OF REMEDIUM LIFECARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-71%
-95%
-95%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF REMEDIUM LIFECARE



REMEDIUM LIFECARE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF REMEDIUM LIFECARE

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
1.34
0
0
0.45
-
-
-
-
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF REMEDIUM LIFECARE

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF REMEDIUM LIFECARE

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-67.72%
1058.18%
8.57%
8.56%
-94.65%
-29.71%
-76.37%
-72.81%
QtrlyTrend
-2
Latest Qtr: Sep2024
Quarterly Result Analysis →


REMEDIUM LIFECARE related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about REMEDIUM LIFECARE


Is REMEDIUM LIFECARE good for long term investment?

As on Dec 11,2024, the Fundamentals of REMEDIUM LIFECARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of REMEDIUM LIFECARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is REMEDIUM LIFECARE UnderValued or OverValued?

As on Dec 11,2024, REMEDIUM LIFECARE is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of REMEDIUM LIFECARE ?

As on Dec 11,2024, the Intrinsic Value of REMEDIUM LIFECARE is Rs. 104.36 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 19.02
Fair Value [Median EV / Sales Model] : Rs. 104.36
Fair Value [Median Price / Sales Model] : Rs. 111.19
Estimated Median Fair Value of REMEDIUM LIFECARE : Rs. 104.36

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is REMEDIUM LIFECARE trading at a Premium or Discount?

As on Dec 11,2024, REMEDIUM LIFECARE is trading at a Discount of -95% based on the estimates of Median Intrinsic Value!